CEO Bilotto buys 100.0K shares of SVC at $1.20 as stock down 58.2% YTD; 4 other insiders also bought in past 14 days
Christopher J. Bilotto, President and CEO, purchased 100,000 shares at $1.20 on April 2, 2026, increasing his holdings by 50.4% to 298,369 shares. The purchase occurs against a backdrop of significant stock weakness: SVC is trading 58.2% below its 52-week high and has declined 43.8% over the past 30 days. Fundamentally, the company generated $478.8M in quarterly revenue but reported a net loss of $-46.9M and has posted negative full-year net income, reflecting sustained operational struggles. The timing of this purchase coincides with a cluster of 4 other insider buys within the past 14 days, suggesting coordinated or reactive positioning in response to deteriorated valuations. However, the CEO's own cross-ticker track record shows minimal success: 1 prior buy with an average 90-day return of -1.4% and a 0.00% win rate, providing little evidence that this transaction signals a contrarian opportunity.
CEO Bilotto buys 20,000 DHC shares at $4.89; holds 266,284 shares post-transaction amid -$164.0M net income
President and CEO Christopher J. Bilotto purchased 20,000 shares at $4.89 on 2025-12-15, increasing his holdings by 8.1% to 266,284 shares total. This open-market purchase occurred while the company reported negative net income of $-164.0M despite quarterly revenue of $388.7M, signaling structural profitability challenges. The stock has recovered 9.3% over the past 90 days and is currently trading at $4.82, only 2.4% below its 52-week high of $4.94. The insider's accumulation during a period of significant financial losses—while the company simultaneously carries a market capitalization of $1.2B—presents a mixed signal requiring closer examination of whether this reflects conviction in a turnaround or other considerations.
